CN106511110B - 二氢燕麦生物碱d盐类化合物作为化妆品活性成分的应用及其合成方法 - Google Patents
二氢燕麦生物碱d盐类化合物作为化妆品活性成分的应用及其合成方法 Download PDFInfo
- Publication number
- CN106511110B CN106511110B CN201610942482.1A CN201610942482A CN106511110B CN 106511110 B CN106511110 B CN 106511110B CN 201610942482 A CN201610942482 A CN 201610942482A CN 106511110 B CN106511110 B CN 106511110B
- Authority
- CN
- China
- Prior art keywords
- oat alkaloid
- dihydro oat
- dihydro
- alkaloid
- salt compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 alkaloid D salt compounds Chemical class 0.000 title claims abstract description 77
- 238000010189 synthetic method Methods 0.000 title claims abstract description 15
- 239000002537 cosmetic Substances 0.000 title abstract description 18
- 239000004480 active ingredient Substances 0.000 title abstract description 7
- KYTDBKDWDOVRLJ-FQBRJNOBSA-N 1,2-dihydro-2,11-epoxycephalotaxine Chemical compound O1C(OC)([C@H]([C@H]2C3=C4)O)C[C@]52CCCN5CC1C3=CC1=C4OCO1 KYTDBKDWDOVRLJ-FQBRJNOBSA-N 0.000 claims abstract description 61
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 17
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- 238000006386 neutralization reaction Methods 0.000 claims description 12
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims description 11
- ZDSSCYCDBASEJQ-UHFFFAOYSA-N N-malonylanthranilic acid Chemical compound OC(=O)CC(=O)NC1=CC=CC=C1C(O)=O ZDSSCYCDBASEJQ-UHFFFAOYSA-N 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 8
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- 239000004475 Arginine Substances 0.000 claims description 5
- 239000004472 Lysine Substances 0.000 claims description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229940000635 beta-alanine Drugs 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 230000036571 hydration Effects 0.000 claims description 4
- 238000006703 hydration reaction Methods 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 3
- 150000001767 cationic compounds Chemical class 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- 229910001411 inorganic cation Inorganic materials 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 239000012429 reaction media Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 25
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 30
- 235000019441 ethanol Nutrition 0.000 description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 208000003251 Pruritus Diseases 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 229960004756 ethanol Drugs 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000006837 decompression Effects 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 240000001307 Myosotis scorpioides Species 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 5
- 229920002055 compound 48/80 Polymers 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- 241000256113 Culicidae Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229960002504 capsaicin Drugs 0.000 description 4
- 229910003002 lithium salt Inorganic materials 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 3
- XYVMOLOUBJBNBF-UHFFFAOYSA-N 3h-1,3-oxazol-2-one Chemical class OC1=NC=CO1 XYVMOLOUBJBNBF-UHFFFAOYSA-N 0.000 description 3
- 240000006409 Acacia auriculiformis Species 0.000 description 3
- 239000004381 Choline salt Substances 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101100233695 Mus musculus Itch gene Proteins 0.000 description 3
- 201000009053 Neurodermatitis Diseases 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 235000017663 capsaicin Nutrition 0.000 description 3
- 235000019417 choline salt Nutrition 0.000 description 3
- 208000010247 contact dermatitis Diseases 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- UOURRHZRLGCVDA-UHFFFAOYSA-D pentazinc;dicarbonate;hexahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[O-]C([O-])=O.[O-]C([O-])=O UOURRHZRLGCVDA-UHFFFAOYSA-D 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- IDUUXROOZBOOPH-QHHAFSJGSA-N 2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1NC(=O)\C=C\C1=CC=C(O)C(O)=C1 IDUUXROOZBOOPH-QHHAFSJGSA-N 0.000 description 1
- CVQUVFAGYIPOEK-UHFFFAOYSA-N 3h-1,3-oxazol-2-one;propan-2-one Chemical compound CC(C)=O.O=C1NC=CO1 CVQUVFAGYIPOEK-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 150000001484 arginines Chemical class 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 125000000017 cortisol group Chemical group 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000010129 solution processing Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
序号 | 测试化合物 | 抑制率% |
1 | 生理盐水 | 0 |
2 | 氢化可的松(0.1%) | 83.0 |
3 | 二氢燕麦生物碱D钠盐(30ppm) | 83.9 |
4 | 二氢燕麦生物碱D钾盐(30ppm) | 84.6 |
5 | 二氢燕麦生物碱D锂盐(30ppm) | 86.3 |
6 | 二氢燕麦生物碱D钙盐(30ppm) | 76.8 |
7 | 二氢燕麦生物碱D锌盐(30ppm) | 77.4 |
8 | 二氢燕麦生物碱D镁盐(30ppm) | 78.9 |
9 | 二氢燕麦生物碱D铵盐(30ppm) | 82.5 |
10 | 二氢燕麦生物碱D胆碱盐(30ppm) | 88.3 |
11 | 二氢燕麦生物碱D赖氨酸盐(30ppm) | 89.2 |
12 | 二氢燕麦生物碱D精氨酸盐(30ppm) | 87.3 |
序号 | 测试化合物 | 抑制率% |
1 | 生理盐水 | 0 |
2 | 二氢燕麦生物碱D钠盐(30ppm) | 56.6 |
3 | 二氢燕麦生物碱D钾盐(30ppm) | 57.3 |
4 | 二氢燕麦生物碱D锂盐(30ppm) | 55.8 |
5 | 二氢燕麦生物碱D钙盐(30ppm) | 54.9 |
6 | 二氢燕麦生物碱D锌盐(30ppm) | 53.2 |
7 | 二氢燕麦生物碱D镁盐(30ppm) | 55.3 |
8 | 二氢燕麦生物碱D铵盐(30ppm) | 58.2 |
9 | 二氢燕麦生物碱D胆碱盐(30ppm) | 62.8 |
10 | 二氢燕麦生物碱D赖氨酸盐(30ppm) | 66.5 |
11 | 二氢燕麦生物碱D精氨酸盐(30ppm) | 63.2 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610942482.1A CN106511110B (zh) | 2016-10-25 | 2016-10-25 | 二氢燕麦生物碱d盐类化合物作为化妆品活性成分的应用及其合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610942482.1A CN106511110B (zh) | 2016-10-25 | 2016-10-25 | 二氢燕麦生物碱d盐类化合物作为化妆品活性成分的应用及其合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106511110A CN106511110A (zh) | 2017-03-22 |
CN106511110B true CN106511110B (zh) | 2019-10-01 |
Family
ID=58292023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610942482.1A Active CN106511110B (zh) | 2016-10-25 | 2016-10-25 | 二氢燕麦生物碱d盐类化合物作为化妆品活性成分的应用及其合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106511110B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107412600B (zh) * | 2017-08-15 | 2021-03-09 | 广州无添加主义化妆品有限公司 | 一种燕麦生物碱的提取方法、喷雾剂及其制备方法 |
CN107868019A (zh) * | 2017-11-09 | 2018-04-03 | 福州美乐莲生物科技有限公司 | 二氢燕麦生物碱类化合物、衍生物及其制备方法和应用 |
CN110448509A (zh) * | 2019-09-06 | 2019-11-15 | 奢脉国际化妆品(北京)有限公司 | 一种具有舒敏修复功效的多肽精华液及其制备方法 |
CN110981925B (zh) * | 2019-11-18 | 2021-05-25 | 福州百草堂医药科技有限公司 | 二氢燕麦生物碱d葡萄糖苷或其盐类化合物及其在化妆品中的应用 |
CN110742820A (zh) * | 2019-11-29 | 2020-02-04 | 福州百草堂医药科技有限公司 | 二氢燕麦生物碱d盐化妆品试剂及其用途 |
CN113274339A (zh) * | 2021-05-27 | 2021-08-20 | 马应龙大健康有限公司 | 一种具有止痒保湿功效的硅油乳膏及其制备方法 |
CN114369040B (zh) * | 2022-03-21 | 2022-07-05 | 广州同隽医药科技有限公司 | 2-(3-(对羟苯基)-丙酰胺基)-苯甲酸葡糖胺盐及其制备方法 |
CN115252451A (zh) * | 2022-08-08 | 2022-11-01 | 福州碧昂缇生物科技有限公司 | 二氢燕麦生物碱d钾在化妆品中的用途 |
CN115626879B (zh) * | 2022-10-08 | 2024-01-30 | 广州同隽医药科技有限公司 | 一种2-苯丙酰胺基-苯甲酸衍生物的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005016870A1 (en) * | 2003-08-14 | 2005-02-24 | Smithkline Beecham Corporation | 2-substituted benzoic acid derivatives as hm74a receptor agonists |
CN103919772A (zh) * | 2014-03-31 | 2014-07-16 | 上海鲁冠生物科技有限公司 | 抗菌止痒乳膏及其制备方法和用途 |
CN104418764A (zh) * | 2013-09-11 | 2015-03-18 | 上海伊明化学科技有限公司 | 一种二氢燕麦酰基邻氨基苯甲酸d合成方法 |
-
2016
- 2016-10-25 CN CN201610942482.1A patent/CN106511110B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005016870A1 (en) * | 2003-08-14 | 2005-02-24 | Smithkline Beecham Corporation | 2-substituted benzoic acid derivatives as hm74a receptor agonists |
CN104418764A (zh) * | 2013-09-11 | 2015-03-18 | 上海伊明化学科技有限公司 | 一种二氢燕麦酰基邻氨基苯甲酸d合成方法 |
CN103919772A (zh) * | 2014-03-31 | 2014-07-16 | 上海鲁冠生物科技有限公司 | 抗菌止痒乳膏及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN106511110A (zh) | 2017-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106511110B (zh) | 二氢燕麦生物碱d盐类化合物作为化妆品活性成分的应用及其合成方法 | |
CN1243541C (zh) | 2-(α-羟基戊基)苯甲酸盐及其制法和用途 | |
KR101198244B1 (ko) | 영양제, 화장품 및 의약품에서 신규 셀레노하이드록시산 및이의 유도체 용도 | |
CN113181339B (zh) | 一种醛基类化合物的药物用途 | |
CA1270196A (en) | Inorganic mineral compound to be used internally as a dietary mineral supplement or mixed with an emollient base to be used externally for the treatment of skin and inflammatory disorders | |
JP2002226457A (ja) | 新規シスチン誘導体及び炎症因子活性化抑制剤 | |
CN101402565B (zh) | 卤代2-(a-羟基戊基)苯甲酸盐及其制法和用途 | |
JPS63313732A (ja) | 安息香酸誘導体およびその用途 | |
WO2012173217A1 (ja) | ピロロキノリンキノンジナトリウム塩の結晶およびその製造方法 | |
KR102029078B1 (ko) | 새로운 올리고당 화합물 및 이의 미용학적 용도 | |
CN111960972B (zh) | 牛磺酸镁盐及牛磺酸镁配合物的制备工艺与应用 | |
CN101486730A (zh) | 一种磷酸肌酸钠化合物及其合成方法 | |
CN108033903A (zh) | 一种dl-对甲砜基苯丝氨酸乙酯带水酯化的合成工艺 | |
CN104004040B (zh) | 一种利用草酰氯制备胞磷胆碱钠的方法 | |
TW200536856A (en) | Process for producing flavone C glycoside derivatives | |
CN103896798A (zh) | 一种四环素提纯工艺 | |
CN102190644B (zh) | 手性3-羟基吡啶-4-酮类衍生物及其合成和用途 | |
JP5138341B2 (ja) | 抗アレルギー剤 | |
CN114224877A (zh) | 一种中和乳酸抑制谷氨酰胺酵解提高膜电位的抗癌配方溶液 | |
JP5937450B2 (ja) | ヒアルロニダーゼ阻害剤 | |
CN109232649B (zh) | 一种四氮唑类脲酶抑制剂型饲料添加剂及其制备方法 | |
JPS63152379A (ja) | 17,18―デヒドロ―アポビンカミノール | |
CN109608494B (zh) | 含有膦酰基的羧酸盐、其制备方法和应用 | |
EP0368758B1 (fr) | Le cystéate de zinc, sa préparation et ses applications pharmaceutiques et cosmétologiques | |
CN116621898A (zh) | 烟酰胺核糖的有机酸盐及其结晶形态、制备方法与用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190920 Address after: 350000 Second Floor of Building 6, No. 9, Jintang Road, Jianxin Town, Cangshan District, Fuzhou City, Fujian Province Patentee after: FUZHOU BAICAOTANG PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: 350000, No. 6, building 9, No. second Jintang Road, Cangshan District, Fujian, Fuzhou Patentee before: FUZHOU MELALYN BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231120 Address after: 366,106 Guanqian Industrial Concentration Zone, Youxi County, Sanming City, Fujian Province Patentee after: Fujian Lianke Technology Co.,Ltd. Address before: Floor 2, building 6, 9 Jintang Road, Jianxin Town, Cangshan District, Fuzhou City, Fujian Province 350000 Patentee before: FUZHOU BAICAOTANG PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |